Email address
[email protected]Contact number
+1 617 951 7000Provided by Ropes & Gray LLP
The attorneys and technical specialists who make up the global life sciences group understand the unique needs of a wide range of clients in the dynamic life sciences industry. We work across practices and geographies to develop cutting-edge solutions that help our clients meet their business goals.
To learn more about our practice, please visit: https://www.ropesgray.com/practices/life-sciences.aspx
Provided by Chambers
Ropes & Gray LLP is well reputed for high-end M&A, capital markets transactions and complex licensing and collaboration deals. The team is well equipped to assist with matters at the intersection of FDA product labeling rules and the First Amendment, contentious regulatory proceedings and patent disputes.
Ropes & Gray LLP represented IQVIA Holdings Inc., in its $2 billion offering in aggregate principal amount of senior notes due 2032.
Provided by Chambers
Ropes & Gray is adept at handling multi-faceted, complex, cross-functional area matters, in part because the team works seamlessly together, bringing in the right expertise at the right time and coordinating efficiently.
Ropes & Gray is thoughtful and provide a business forward approach.
Ropes & Gray has a deep well of experts who respond in a quick and efficient way with practical advice.
Ropes & Gray is adept at handling multi-faceted, complex, cross-functional area matters, in part because the team works seamlessly together, bringing in the right expertise at the right time and coordinating efficiently.
Ropes & Gray is thoughtful and provide a business forward approach.
Ropes & Gray has a deep well of experts who respond in a quick and efficient way with practical advice.
Provided by Chambers
Greg Levine has extensive experience advising biotechnology, pharmaceutical and medical device manufacturers on regulatory matters affecting products throughout their entire lifecycle. He is particularly noted for his work on regulatory strategy, securing marketing authorizations and shaping labeling and promotional campaigns.
Greg's depth is tremendous, but it's his strategic and creative thinking that sets him apart.
Greg provides expert guidance on FDA and advertising and promotion matters, bringing creative, business-focused ideas to complex problems.
Greg is a steady hand through really complex and challenging issues.
Hannah England is a notable practitioner who advises global biotechnology and pharmaceutical companies on licensing and collaboration transactions. She is also noted for her work on asset acquisitions, royalty monetization and research and development financing arrangements.
